Variation in very preterm extrauterine growth in a European multicountry cohort.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
May 2021
Historique:
received: 16 06 2020
revised: 25 10 2020
accepted: 26 10 2020
pubmed: 4 12 2020
medline: 30 4 2021
entrez: 3 12 2020
Statut: ppublish

Résumé

Extrauterine growth restriction (EUGR) among very preterm infants is related to poor neurodevelopment, but lack of consensus on EUGR measurement constrains international research. Our aim was to compare EUGR prevalence in a European very preterm cohort using commonly used measures. Population-based observational study. 19 regions in 11 European countries. 6792 very preterm infants born before 32 weeks' gestational age (GA) surviving to discharge. We investigated two measures based on discharge-weight percentiles with (1) Fenton and (2) Intergrowth (IG) charts and two based on growth velocity (1) birth weight and discharge-weight Z-score differences using Fenton charts and (2) weight-gain velocity using Patel's model. We estimated country-level relative risks of EUGR adjusting for maternal and neonatal characteristics and associations with population differences in healthy newborn size, measured by mean national birth weight at 40 weeks' GA. About twofold differences in EUGR prevalence were observed between countries for all indicators and these persisted after case-mix adjustment. Discharge weight <10th percentile using Fenton charts varied from 24% (Sweden) to 60% (Portugal) and using IG from 13% (Sweden) to 43% (Portugal), while low weight-gain velocity ranged from 35% (Germany) to 62% (UK). Mean term birth weight strongly correlated with both percentile-based measures (Spearman's rho=-0.90 Fenton, -0.84 IG, p<0.01), but not Patel's weight-gain velocity (rho: -0.38, p=0.25). Very preterm infants have a high prevalence of EUGR, with wide variations between countries in Europe. Variability associated with mean term birth weight when using common postnatal growth charts complicates international benchmarking.

Identifiants

pubmed: 33268469
pii: archdischild-2020-319946
doi: 10.1136/archdischild-2020-319946
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

316-323

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Rym El Rafei (R)

Université de Paris, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team,EPOPé, INSERM, INRA, F-75004, Paris, France rym.el-rafei@inserm.fr.
Sorbonne Université, Collège Doctoral, F-75005, Paris, France.

Pierre-Henri Jarreau (PH)

Université de Paris, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team,EPOPé, INSERM, INRA, F-75004, Paris, France.
Université Paris Descartes and Assistance Publique Hôpitaux de Paris, Hôpitaux Universitaire Paris Centre Site Cochin, DHU Risks in pregnancy, Service de Médecine et Réanimation néonatales de Port-Royal, Paris, France.

Mikael Norman (M)

Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Department of Neonatal Medicine, Karolinska Institute, Stockholm, Sweden.

Rolf Felix Maier (RF)

Children's Hospital, Philipps-Universitat Marburg, Marburg, Hessen, Germany.

Henrique Barros (H)

EPIUnit-Institute of Public Health, University of Porto, Porto, Portugal.
Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto, Porto, Portugal.

Patrick Van Reempts (PV)

Neonatology, Laboratory of Experimental Medicine and Pediatrics, Division of Neonatology, University of Antwerp, Antwerp. Study Centre for Perinatal Epidemiology Flanders, Brussels, Belgium.

Pernille Pedersen (P)

Department of Paediatrics, Hvidovre Hospital, Hvidovre, Denmark.

Marina Cuttini (M)

Clinical Care and Management Innovation Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Jennifer Zeitlin (J)

Université de Paris, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team,EPOPé, INSERM, INRA, F-75004, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH